Clinical Trials Logo
  1. Home
  2. Alzheimer's Dementia
  3. NCT01195389

Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease

Alzheimer's Dementia Clinical Trial

Official title:
A Randomized, Single-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety and Efficacy of the Application of Magnetic Fields Using the Resonator for the Treatment of Alzheimer's Disease in Addition to Standard of Care

Clinical Trial Summary

The purpose of this study is to determine if low level magnetic fields can help to improve memory in patients diagnosed with Alzheimer's dementia.

Clinical Trial Description

The purpose of this pilot study is to determine whether application of magnetic fields generated by the Resonator result in statistically significant improvements in cognitive functioning and memory in patients with a diagnosis of Alzheimer's dementia. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01195389
Study type Interventional
Source pico-tesla Magnetic Therapies, LLC
Contact Amanda Smith, MD
Phone 813-974-4355
Status Recruiting
Phase N/A
Start date December 2010
Completion date October 2011
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02959502 - Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression N/A
Completed NCT02759887 - Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD) N/A
Completed NCT01002586 - Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia N/A
Terminated NCT02804789 - European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)
Completed NCT02190084 - Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia Phase 4
Completed NCT01409564 - Cilostazol Augmentation Study in Dementia Phase 4
Completed NCT01608217 - Delta-THC in Dementia Phase 2
Completed NCT04748263 - Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)
Completed NCT03928405 - Effect of Virtual Reality on Balance and Gait Speed With Alzheimer's Dementia N/A
Completed NCT01585272 - Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia Phase 4
Withdrawn NCT04812769 - Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases N/A